TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study of a Focused Palliative Care Intervention for Recently Hospitalized High-Risk Patients With Heart Failure
Brief Summary: This small pilot study will be assessing the the impact of a standardized, social-worker led, longitudinal palliative care intervention on alignment of patient and physician understanding of prognosis and goals of care. Secondary objectives include assessing the impact of this intervention on documentation of advanced care planning and end of life preferences, symptom burden, quality of life and health care utilization.


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Arm Label: Verbal Information and Discussion; Type: EXPERIMENTAL; Interventions: Other: Verbal Information and Discussion | Intervention Type: OTHER; Name: Verbal Information and Discussion; Assigned to Arm(s): Verbal Information and Discussion | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
B: Arm Label: Goc Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: goals of care | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: goals of care; Assigned to Arm(s): Goc Intervention
C: Arm Label: Integrated care; Type: EXPERIMENTAL; Interventions: Other: Integrated care | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Integrated care; Assigned to Arm(s): Integrated care | Intervention Type: OTHER; Name: Integrated care; Assigned to Arm(s): Integrated care
D: Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention (ACP) arm; Type: EXPERIMENTAL; Interventions: Behavioral: ACP | Intervention Type: BEHAVIORAL; Name: ACP; Assigned to Arm(s): Intervention (ACP) arm

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus (ADVAGRAF) in Kidney Transplant Recipients
Brief Summary: Aim The primary objective of this study is to compare medication adherence with medical therapy in patients receiving once-daily versus twice-daily tacrolimus regimens.

Participants 60 adult renal transplant patients randomized 1:2 into twice-daily and once-daily tacrolimus groups

Outcomes The primary outcome will be medication adherence to the once-daily and twice-daily regimens, measured in terms of implementation. Secondary outcomes will include graft and patient survival, renal function and adverse events. Follow up - 12 months


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: behavioral adaptation and symptom management | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: behavioral adaptation and symptom management; Assigned to Arm(s): 1
B: Arm Label: Advagraf; Type: EXPERIMENTAL; Interventions: Drug: Advagraf | Arm Label: Prograf; Type: ACTIVE_COMPARATOR; Interventions: Drug: Prograf | Intervention Type: DRUG; Name: Advagraf; Assigned to Arm(s): Advagraf | Intervention Type: DRUG; Name: Prograf; Assigned to Arm(s): Prograf
C: Arm Label: Tacrolimus BID; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus BID | Arm Label: Advagraf QD; Type: ACTIVE_COMPARATOR; Interventions: Drug: Advagraf QD | Intervention Type: DRUG; Name: Tacrolimus BID; Assigned to Arm(s): Tacrolimus BID | Intervention Type: DRUG; Name: Advagraf QD; Assigned to Arm(s): Advagraf QD
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: TAKE IT Strategy | Intervention Type: BEHAVIORAL; Name: TAKE IT Strategy; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Propofol and Dexmedetomidine to Treat Hyperactive and Mixed ICU Delirium - the Basel ProDex Randomized Trial
Brief Summary: In this randomized study, the investigators aim to test the hypothesis that the reinstitution of a normal circadian rhythm by continuous infusions of dexmedetomidine compared to propofol between 8pm and 6am after diagnosis of hyperactive or mixed delirium, decreases the duration of delirium. The infusions might have to be repeated several times to achieve resolution of delirium.


Options:
A: Arm Label: Dexmedetomidine; Type: EXPERIMENTAL; Interventions: Drug: Dexmedetomidine | Arm Label: Propofol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Propofol | Intervention Type: DRUG; Name: Dexmedetomidine; Assigned to Arm(s): Dexmedetomidine | Intervention Type: DRUG; Name: Propofol; Assigned to Arm(s): Propofol
B: Arm Label: Dexmedetomidine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexmedetomidine | Arm Label: Saline placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline placebo | Intervention Type: DRUG; Name: Dexmedetomidine; Assigned to Arm(s): Dexmedetomidine | Intervention Type: DRUG; Name: Saline placebo; Assigned to Arm(s): Saline placebo
C: Arm Label: haloperidol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Haloperidol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Haloperidol; Assigned to Arm(s): haloperidol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: dexmedetomidine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: haloperidol | Intervention Type: DRUG; Name: dexmedetomidine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: haloperidol; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Multicenter, Randomized, Placebo-Controlled Study of Atezolizumab (Anti-PD-L1 Antibody) as Monotherapy and in Combination With Platinum-Based Chemotherapy in Patients With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
Brief Summary: A Phase III, randomised study of atezolizumab alone and in combination with chemotherapy versus chemotherapy alone in participants with untreated advanced urothelial cancer.


Options:
A: Arm Label: Atezolizumab+Gemcitabine+Carboplatin/Cisplatin; Type: EXPERIMENTAL; Interventions: Drug: Atezolizumab, Drug: Carboplatin, Drug: Gemcitabine, Drug: Cisplatin | Arm Label: Placebo+Gemcitabine+Carboplatin/Cisplatin; Type: PLACEBO_COMPARATOR; Interventions: Drug: Carboplatin, Drug: Gemcitabine, Other: Placebo, Drug: Cisplatin | Arm Label: Atezolizumab Monotherapy; Type: EXPERIMENTAL; Interventions: Drug: Atezolizumab | Intervention Type: DRUG; Name: Atezolizumab; Assigned to Arm(s): Atezolizumab Monotherapy, Atezolizumab+Gemcitabine+Carboplatin/Cisplatin | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): Atezolizumab+Gemcitabine+Carboplatin/Cisplatin, Placebo+Gemcitabine+Carboplatin/Cisplatin | Intervention Type: DRUG; Name: Gemcitabine; Assigned to Arm(s): Atezolizumab+Gemcitabine+Carboplatin/Cisplatin, Placebo+Gemcitabine+Carboplatin/Cisplatin | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo+Gemcitabine+Carboplatin/Cisplatin | Intervention Type: DRUG; Name: Cisplatin; Assigned to Arm(s): Atezolizumab+Gemcitabine+Carboplatin/Cisplatin, Placebo+Gemcitabine+Carboplatin/Cisplatin
B: Arm Label: Nivolumab; Type: EXPERIMENTAL; Interventions: Drug: Nivolumab | Intervention Type: DRUG; Name: Nivolumab; Assigned to Arm(s): Nivolumab
C: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Drug: paclitaxel, Drug: vinflunine, Drug: docetaxel | Arm Label: Pembrolizumab; Type: EXPERIMENTAL; Interventions: Biological: pembrolizumab | Intervention Type: BIOLOGICAL; Name: pembrolizumab; Assigned to Arm(s): Pembrolizumab | Intervention Type: DRUG; Name: paclitaxel; Assigned to Arm(s): Control | Intervention Type: DRUG; Name: vinflunine; Assigned to Arm(s): Control | Intervention Type: DRUG; Name: docetaxel; Assigned to Arm(s): Control
D: Arm Label: Cohort A: Triple Negative Breast Cancer; Type: EXPERIMENTAL; Interventions: Biological: Pembrolizumab | Arm Label: Cohort B: Head & Neck Cancer; Type: EXPERIMENTAL; Interventions: Biological: Pembrolizumab | Arm Label: Cohort C: Urothelial Cancer; Type: EXPERIMENTAL; Interventions: Biological: Pembrolizumab | Arm Label: Cohort D: Gastric Cancer; Type: EXPERIMENTAL; Interventions: Biological: Pembrolizumab | Arm Label: Cohort B2: Head & Neck Cancer Expansion; Type: EXPERIMENTAL; Interventions: Biological: Pembrolizumab | Intervention Type: BIOLOGICAL; Name: Pembrolizumab; Assigned to Arm(s): Cohort A: Triple Negative Breast Cancer, Cohort B2: Head & Neck Cancer Expansion, Cohort B: Head & Neck Cancer, Cohort C: Urothelial Cancer, Cohort D: Gastric Cancer

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Meeting the Needs of Pregnant Women With PTSD in Prenatal Care
Brief Summary: The objectives of this research study are to screen 750 pregnant women at risk of trauma-related stress symptoms, and adapt and test an evidence-based intervention for pregnant women with PTSD and sub-threshold PTSD symptoms served by two public payer community health centers.


Options:
A: Arm Label: TAU; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: TAU | Arm Label: DCM; Type: EXPERIMENTAL; Interventions: Behavioral: Care Management for Postpartum Depression | Intervention Type: BEHAVIORAL; Name: Care Management for Postpartum Depression; Assigned to Arm(s): DCM | Intervention Type: BEHAVIORAL; Name: TAU; Assigned to Arm(s): TAU
B: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Adapted Seeking Safety Intervention | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Adapted Seeking Safety Intervention; Assigned to Arm(s): Experimental
C: Arm Label: Family Foundations coparenting program; Type: EXPERIMENTAL; Interventions: Behavioral: Family Foundations coparenting program | Arm Label: Home visiting; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home visiting | Intervention Type: BEHAVIORAL; Name: Family Foundations coparenting program; Assigned to Arm(s): Family Foundations coparenting program | Intervention Type: BEHAVIORAL; Name: Home visiting; Assigned to Arm(s): Home visiting
D: Arm Label: Mom Power Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Mom Power Intervention Group | Arm Label: Mom Power Attentional Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mom Power Attentional Control Group | Intervention Type: BEHAVIORAL; Name: Mom Power Intervention Group; Assigned to Arm(s): Mom Power Intervention Group | Intervention Type: BEHAVIORAL; Name: Mom Power Attentional Control Group; Assigned to Arm(s): Mom Power Attentional Control Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Developing a Brief Early Cognitive Intervention for PTSD and Alcohol Misuse
Brief Summary: The broad aim of this study is to develop and test a brief intervention that can be implemented in the immediate weeks following sexual assault to decrease likelihood of developing posttraumatic stress disorder (PTSD) or alcohol misuse. The first phase of the study will enroll 6 women to complete a brief, cognitive therapy protocol and provide feedback on the intervention (open trial). The second phase of the study will recruit 76 women to complete either the intervention (38 women) or assessment only (38 women) to test the effects of the intervention on both PTSD symptoms and alcohol use behavior as compared to natural recovery following assault.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: TF-CBT | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment as Usual (TAU) | Intervention Type: OTHER; Name: TF-CBT; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Treatment as Usual (TAU); Assigned to Arm(s): 2
B: Arm Label: CBT for PTSD; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy for PTSD | Arm Label: Imagery Rehearsal Therapy + CBT for PTSD; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy for PTSD, Behavioral: Imagery Rehearsal Therapy | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for PTSD; Assigned to Arm(s): CBT for PTSD, Imagery Rehearsal Therapy + CBT for PTSD | Intervention Type: BEHAVIORAL; Name: Imagery Rehearsal Therapy; Assigned to Arm(s): Imagery Rehearsal Therapy + CBT for PTSD
C: Arm Label: Written Exposure Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Written Exposure Therapy | Arm Label: Written Exposure Therapy Integrated with Cognitive Behavioral Therapy for Alcohol Use Disorder; Type: EXPERIMENTAL; Interventions: Behavioral: Written Exposure Therapy Integrated with Cognitive Behavioral Therapy for Alcohol Use Disorder | Intervention Type: BEHAVIORAL; Name: Written Exposure Therapy Integrated with Cognitive Behavioral Therapy for Alcohol Use Disorder; Assigned to Arm(s): Written Exposure Therapy Integrated with Cognitive Behavioral Therapy for Alcohol Use Disorder | Intervention Type: BEHAVIORAL; Name: Written Exposure Therapy; Assigned to Arm(s): Written Exposure Therapy
D: Arm Label: Brief Cognitive Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief Cognitive Therapy | Arm Label: Assessment Only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Brief Cognitive Therapy; Assigned to Arm(s): Brief Cognitive Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Developing a Brief Early Cognitive Intervention for PTSD and Alcohol Misuse
Brief Summary: The broad aim of this study is to develop and test a brief intervention that can be implemented in the immediate weeks following sexual assault to decrease likelihood of developing posttraumatic stress disorder (PTSD) or alcohol misuse. The first phase of the study will enroll 6 women to complete a brief, cognitive therapy protocol and provide feedback on the intervention (open trial). The second phase of the study will recruit 76 women to complete either the intervention (38 women) or assessment only (38 women) to test the effects of the intervention on both PTSD symptoms and alcohol use behavior as compared to natural recovery following assault.


Options:
A: Arm Label: PPRS video; Type: EXPERIMENTAL; Interventions: Behavioral: PPRS | Arm Label: PIRI video; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: PIRI | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: PPRS; Assigned to Arm(s): PPRS video | Intervention Type: BEHAVIORAL; Name: PIRI; Assigned to Arm(s): PIRI video
B: Arm Label: Eye Movement Desensitization Reprocessing (EMDR); Type: EXPERIMENTAL; Interventions: Behavioral: Eye Movement Desensitization Reprocessing (EMDR) | Intervention Type: BEHAVIORAL; Name: Eye Movement Desensitization Reprocessing (EMDR); Assigned to Arm(s): Eye Movement Desensitization Reprocessing (EMDR)
C: Arm Label: Brief Cognitive Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief Cognitive Therapy | Arm Label: Assessment Only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Brief Cognitive Therapy; Assigned to Arm(s): Brief Cognitive Intervention
D: Arm Label: CBT-E; Type: EXPERIMENTAL; Interventions: Behavioral: Specific Modules, Behavioral: Cognitive behavioral therapy | Arm Label: CBT-C; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive behavioral therapy | Intervention Type: BEHAVIORAL; Name: Specific Modules; Assigned to Arm(s): CBT-E | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy; Assigned to Arm(s): CBT-C, CBT-E

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa
Brief Summary: The purpose of this study is to compare three strategies for finding TB cases in a rural Sub-Saharan African setting: 1) Screening all attendees of primary care clinics for TB; 2) Conducting household contact investigations of newly diagnosed TB cases; 3) Providing incentives to newly diagnosed TB cases and their contacts to promote contact screening for TB. For each intervention, investigators will measure comparative effectiveness in terms of cases identified as well as the cost-effectiveness and feasibility of implementation.


Options:
A: Arm Label: Facility-based screening; Type: EXPERIMENTAL; Interventions: Other: Active TB case finding | Arm Label: Contact screening; Type: EXPERIMENTAL; Interventions: Other: Active TB case finding | Intervention Type: OTHER; Name: Active TB case finding; Assigned to Arm(s): Contact screening, Facility-based screening
B: Arm Label: 0.1 µg/0.1 mL C-Tb; Type: EXPERIMENTAL; Interventions: Biological: C-Tb | Arm Label: 2 T.U. Tuberculin PPD RT 23 SSI; Type: ACTIVE_COMPARATOR; Interventions: Biological: 2 T.U. Tuberculin PPD RT 23 SSI | Intervention Type: BIOLOGICAL; Name: C-Tb; Assigned to Arm(s): 0.1 µg/0.1 mL C-Tb | Intervention Type: BIOLOGICAL; Name: 2 T.U. Tuberculin PPD RT 23 SSI; Assigned to Arm(s): 2 T.U. Tuberculin PPD RT 23 SSI
C: Intervention Type: OTHER; Name: Development of a diagnosis algorithm; Assigned to Arm(s): N/A
D: Arm Label: 0.1 µg/0.1 mL C-Tb; Type: EXPERIMENTAL; Interventions: Biological: C-Tb | Arm Label: 2 T.U. Tuberculin PPD RT 23 SSI; Type: ACTIVE_COMPARATOR; Interventions: Biological: 2 T.U. Tuberculin PPD RT 23 SSI | Intervention Type: BIOLOGICAL; Name: C-Tb; Assigned to Arm(s): 0.1 µg/0.1 mL C-Tb | Intervention Type: BIOLOGICAL; Name: 2 T.U. Tuberculin PPD RT 23 SSI; Assigned to Arm(s): 2 T.U. Tuberculin PPD RT 23 SSI

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pharmacological Treatment of Narcotic Neonatal Withdrawal
Brief Summary: Three different drugs are used in a randomised, double blind, clinical multi-centre trial with three arms. Major objective is to investigate the duration of drug treatment based on the Finnegan score. Secondary objectives are to document weight gain, the need for adding a second drug when the first drug is not effective enough and possible side effects such as convulsions.


Options:
A: Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine
B: Arm Label: Low lactose formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Low lactose or regular formula | Arm Label: Regular formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Low lactose or regular formula | Intervention Type: OTHER; Name: Low lactose or regular formula; Assigned to Arm(s): Low lactose formula, Regular formula
C: Arm Label: Phenobarbital; Type: EXPERIMENTAL; Interventions: Drug: Phenobarbital | Arm Label: Chlorpromazine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chlorpromazine | Arm Label: Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine | Intervention Type: DRUG; Name: Phenobarbital; Assigned to Arm(s): Phenobarbital | Intervention Type: DRUG; Name: Chlorpromazine; Assigned to Arm(s): Chlorpromazine | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine
D: Arm Label: Standard therapy plus Aromatherapy; Type: EXPERIMENTAL; Interventions: Drug: lavender and chamomile essential oils | Arm Label: Standard therapy ALONE; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: lavender and chamomile essential oils; Assigned to Arm(s): Standard therapy plus Aromatherapy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pharmacological Treatment of Narcotic Neonatal Withdrawal
Brief Summary: Three different drugs are used in a randomised, double blind, clinical multi-centre trial with three arms. Major objective is to investigate the duration of drug treatment based on the Finnegan score. Secondary objectives are to document weight gain, the need for adding a second drug when the first drug is not effective enough and possible side effects such as convulsions.


Options:
A: Arm Label: Song of Kin; Type: EXPERIMENTAL; Interventions: Behavioral: Song of Kin | Arm Label: Gato box; Type: EXPERIMENTAL; Interventions: Other: Gato box | Arm Label: Ocean disc; Type: EXPERIMENTAL; Interventions: Other: Ocean disc | Arm Label: Contingent singing; Type: EXPERIMENTAL; Interventions: Other: Contingent singing | Arm Label: Tonal Vocal holding; Type: EXPERIMENTAL; Interventions: Other: Tonal Vocal holding | Arm Label: Muted shaker; Type: EXPERIMENTAL; Interventions: Other: Muted shaker | Intervention Type: BEHAVIORAL; Name: Song of Kin; Assigned to Arm(s): Song of Kin | Intervention Type: OTHER; Name: Gato box; Assigned to Arm(s): Gato box | Intervention Type: OTHER; Name: Ocean disc; Assigned to Arm(s): Ocean disc | Intervention Type: OTHER; Name: Contingent singing; Assigned to Arm(s): Contingent singing | Intervention Type: OTHER; Name: Tonal Vocal holding; Assigned to Arm(s): Tonal Vocal holding | Intervention Type: OTHER; Name: Muted shaker; Assigned to Arm(s): Muted shaker
B: Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine
C: Arm Label: Standard therapy plus Aromatherapy; Type: EXPERIMENTAL; Interventions: Drug: lavender and chamomile essential oils | Arm Label: Standard therapy ALONE; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: lavender and chamomile essential oils; Assigned to Arm(s): Standard therapy plus Aromatherapy
D: Arm Label: Phenobarbital; Type: EXPERIMENTAL; Interventions: Drug: Phenobarbital | Arm Label: Chlorpromazine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chlorpromazine | Arm Label: Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine | Intervention Type: DRUG; Name: Phenobarbital; Assigned to Arm(s): Phenobarbital | Intervention Type: DRUG; Name: Chlorpromazine; Assigned to Arm(s): Chlorpromazine | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine

Answer: D